Form 4: Cencora SVP & Chief Accounting Officer Sells Over 3,000 Shares of Common Stock

Lazarus Krikorian, SVP & Chief Accounting Officer of Cencora, Inc., reported the sale of 3,000 shares of company common stock for approximately $866,816 on May 29, 2025.

Summary

• Lazarus Krikorian, the Senior Vice President and Chief Accounting Officer of Cencora, Inc. (COR), reported transactions involving the company's common stock.
• On May 29, 2025, Mr. Krikorian sold 2,992 shares of Common Stock at a price of $288.96 per share, totaling approximately $864,504.32.
• On the same date, an additional 8 shares of Common Stock were sold at a price of $289.06 per share, totaling approximately $2,312.48.
• The total number of shares sold across these two transactions was 3,000.
• The total proceeds from these sales amounted to approximately $866,816.80.
• Following these transactions, Mr. Krikorian beneficially owns 17,154 shares of Cencora Common Stock.
• The reported sales were not indicated as being made pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a factual report of an insider stock sale. While insider selling can sometimes be viewed negatively, this is a routine disclosure and the amount, while significant for the individual, is not exceptionally large in the context of a major public company. The absence of a 10b5-1 plan adds a slight nuance but does not drastically alter the overall neutral sentiment for a Form 4.

Negatives

• An insider, the SVP & Chief Accounting Officer, sold 3,000 shares of common stock, representing approximately 14.88% of his prior holdings.
• The sales were not conducted under a Rule 10b5-1 trading plan, which might suggest a discretionary decision to sell rather than a pre-scheduled liquidity event.

Industry Context

This filing is a routine disclosure of an insider stock transaction within the pharmaceutical distribution and healthcare services industry. Insider sales are common for various personal financial planning reasons and do not inherently indicate a negative outlook on the company or industry, though they are closely watched by investors.

Stakeholder Impact

• Shareholders: May observe the insider sale as a data point for management's confidence, though such sales are common and often for personal financial reasons. The sale of approximately 14.88% of the officer's holdings could be noted.

Key Dates

Keywords

Cencora, COR, Insider Trading, Form 4, Stock Sale, Lazarus Krikorian, Beneficial Ownership, Officer Transaction